Genetic analysis of short children with apparent growth hormone insensitivity

Hormone Research in Paediatrics

Volumn 77, Issue 5, 2012, Pages 320-333

  Wit, J M ^a   Van Duyvenvoorde, H A ^a   Scheltinga, S A ^a   De Bruin, S ^a   Hafkenscheid, L ^a   Kant, S G ^a   Ruivenkamp, C A L ^a   Gijsbers, A C J ^a   Van Doorn, J ^b   Feigerlova, E ^c   Noordam, C ^d   Walenkamp, M J ^e   Claahsen Van De Grinten, H ^d   Stouthart, P ^f   Bonapart, I E ^g   Pereira, A M ^a   Gosen, J ^h   Delemarre Van De Waal, H A ^a   Hwa, V ^c   Breuning, M H ^a   Domene H M ⁱ   Oostdijk, W ^a   Losekoot, M ^a   more..

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f Orbis Hospital   (Netherlands)

^g Venizelion General Hospital   (Greece)

^h RIJNLAND HOSPITAL   (Netherlands)

ⁱ HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

Acid labile subunit; Genetics; GH IGF 1 axis; GH1 gene; Growth disorders; Growth hormone; Growth hormone receptor; IGF 1; STAT5B

Indexed keywords

GENOMIC DNA; GHRELIN RECEPTOR; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; STAT5B PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; BODY MASS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DNA SEQUENCE; DOSE RESPONSE; DRUG DOSE ESCALATION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GROWTH HORMONE RELEASE; HEAD CIRCUMFERENCE; HETEROZYGOSITY; HORMONE RESISTANCE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SHORT STATURE; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL FOR DATE INFANT; SYMPTOM;

CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; GLYCOPROTEINS; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR I; MALE; STAT5 TRANSCRIPTION FACTOR;

EID: 84863319925     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000338462     Document Type: Article

References (43)

1. Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH, Cohen P: Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Horm IGF Res 2008; 18: 89-110.
2. Oostdijk W, Grote FK, De Muinck Keizer- Schrama SM, Wit JM: Diagnostic approach in children with short stature. Horm Res 2009; 72: 206-217.
3. Kant SG, Grote F, de Ru MH, Oostdijk W, Zonderland HM, Breuning MH, Wit JM: Radiographic evaluation of children with growth disorders. Horm Res 2007; 68: 310-315.
4. Grote FK, Oostdijk W, De Muinck Keizer- Schrama SM, Van Dommelen P, Van Buuren S, Dekker FW, Ketel AG, Moll HA, Wit JM: The diagnostic work-up of growth failure in secondary healthcare; an evaluation of consensus guidelines. BMC Pediatr 2008; 8: 21.
5. Takahashi Y, Kaji H, Okimura Y, Goji K, Abe H, Chihara K: Brief report: short stature caused by a mutant growth hormone. N Engl J Med 1996; 334: 432-436.
6. Pantel J, Legendre M, Cabrol S, Hilal L, Hajaji Y, Morisset S, Nivot S, Vie-Luton MP, Grouselle D, de Kerdanet M, Kadiri A, Epelbaum J, Le Bouc Y, Amselem S: Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest 2006; 116: 760-768.
7. Godowski PJ, Leung DW, Meacham LR, Galgani JP, Hellmiss R, Keret R, Rotwein PS, Parks JS, Laron Z, Wood WI: Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA 1989; 86: 8083-8087.
8. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A, Heinrich JJ, Rosenfeld RG: Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 2003; 349: 1139-1147.
9. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ: Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996; 335: 1363-1367.
10. Domenée HM, Bengolea SV, Martinez AS, Ropelato MS, Pennisi P, Scaglia P, Heinrich JJ, Jasper HG: Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. N Engl J Med 2004; 350: 570-577.
11. Wit JM, Kiess W, Mullis P: Genetic evaluation of short stature. Best Pract Res Clin. Endocrinol. Metab. 2011; 25: 1-17.
12. David A, Hwa V, Metherell LA, Netchine I, Camacho-Hubner C, Clark AJ, Rosenfeld RG, Savage MO: Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity. Endocr Rev 2011; 32: 472-497.
13. Walenkamp MJ, Karperien M, Pereira AM, Hilhorst-Hofstee Y, Van Doorn J, Chen JW, Mohan S, Denley A, Forbes B, Van Duyvenvoorde HA, Van Thiel SW, Sluimers CA, Bax JJ, de Laat JA, Breuning MB, Romijn JA, Wit JM: Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin. Endocrinol. Metab. 2005; 90: 2855-2864.
14. Van Duyvenvoorde HA, Van Setten PA, Walenkamp MJ, Van Doorn J, Koenig J, Gauguin L, Oostdijk W, Ruivenkamp CA, Losekoot M, Wade JD, De Meyts P, Karperien M, Noordam C, Wit JM: Short stature associated with a novel heterozygous mutation in the insulin-like growth factor-1 gene. J Clin. Endocrinol. Metab. 2010; 95:E363-E367.
15. Van Duyvenvoorde HA, Kempers MJ, Twickler TB, Van Doorn J, Gerver WJ, Noordam C, Losekoot M, Karperien M, Wit JM, Hermus AR: Homozygous and heterozygous expression of a novel mutation of the acidlabile subunit. Eur J Endocrinol 2008; 159: 113-120.
16. Domene HM, Hwa V, Argente J, Wit JM, Camacho- Hubner C, Jasper HG, Pozo J, Van Duyvenvoorde HA, Yakar S, Fofanova- Gambetti OV, Rosenfeld RG: Human acidlabile subunit deficiency: clinical, endocrine and metabolic consequences. Horm Res 2009; 72: 129-141.
17. Fofanova-Gambetti OV, Hwa V, Wit JM, Domene HM, Argente J, Bang P, Hogler W, Kirsch S, Pihoker C, Chiu HK, Cohen L, Jacobsen C, Jasper HG, Haeusler G, Campos- Barros A, Gallego-Gomez E, Gracia-Bouthelier R, Van Duyvenvoorde HA, Pozo J, Rosenfeld RG: Impact of heterozygosity for acid-labile subunitIGFALS) gene mutations on stature: results from the international acid- labile subunit consortium. J Clin. Endocrinol. Metab. 2010; 95: 4184-4191.
18. Rosenfeld RG, Belgorosky A, Camacho- Hubner C, Savage MO, Wit JM, Hwa V: Defects in growth hormone receptor signaling. Trends Endocrinol Metab 2007; 18: 134-141.
19. Sykiotis GP, Plummer L, Hughes VA, Au M, Durrani S, Nayak-Young S, Dwyer AA, Quinton R, Hall JE, Gusella JF, Seminara SB, Crowley WF Jr, Pitteloud N: Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc Natl Acad Sci USA 2010; 107: 15140-15144.
20. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, Jackson AU, Vedantam S, Raychaudhuri S, Ferreira T, Wood AR, Weyant RJ, Segré AV, Speliotes EK, Wheeler E, Soranzo N, Park JH, Yang J, Gudbjartsson D, Heard-Costa NL, Randall JC, Qi L, Vernon Smith A, Mägi R, Pastinen T, Liang L, Heid IM, Luan J, Thorleifsson G, Winkler TW, Goddard ME, Sin Lo K, Palmer C, Workalemahu T, Aulchenko YS, Johansson A, Zillikens MC, Feitosa MF, Esko T, Johnson T, Ketkar S, Kraft P, Mangino M, Prokopenko I, Absher D, Albrecht E, Ernst F, Glazer NL, Hayward C, Hottenga JJ, Jacobs KB, Knowles JW, Kutalik Z, Monda KL, Polasek O, Preuss M, Rayner NW, Robertson NR, Steinthorsdottir V, Tyrer JP, Voight BF, Wiklund F, Xu J, Zhao JH, Nyholt DR, Pellikka N, Perola M, Perry JR, Surakka I, Tammesoo ML, Altmaier EL, Amin N, Aspelund T, Bhangale T, Boucher G, Chasman DI, Chen C, Coin L, Cooper MN, Dixon AL, Gibson Q, Grundberg E, Hao K, Juhani Junttila M, Kaplan LM, Kettunen J, König IR, Kwan T, Lawrence RW, Levinson DF, Lorentzon M, McKnight B, Morris AP, M̈ller M, Suh Ngwa J, Purcell S, Rafelt S, Salem RM, Salvi E, Sanna S, Shi J, Sovio U, Thompson JR, Turchin MC, Vandenput L, Verlaan DJ, Vitart V, White CC, Ziegler A, Almgren P, Balmforth AJ
21. Walenkamp MJE, Wit JM: Genetic disorders in the growth hormone-IGF-I axis. Horm Res 2006; 66: 221-230.
22. Wit JM, Bang P: European perspective on treatment approaches for growth failure. Pediatr Endocrinol Rev 2008; 5(suppl 3):862-868.
23. Fredriks AM, Van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, Roede MJ, Verloove-Vanhorick SP, Wit JM: Continuing positive secular growth change in the Netherlands 1955-1997. Pediatr Res 2000; 47: 316-323.
24. Fredriks AM, Van Buuren S, Van Heel WJ, Dijkman-Neerincx RH, Verloove-Vanhorick SP, Wit JM: Nationwide age references for sitting height, leg length, and sitting height/ height ratio, and their diagnostic value for disproportionate growth disorders. Arch Dis Child 2005; 90: 807-812.
25. Niklasson A, Ericson A, Fryer JG, Karlberg J, Larwence C, Karlberg P: An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age1977-1981). Acta Paediatr Scand 1991; 80: 756-762.
26. Hermanussen M, Cole J: The calculation of target height reconsidered. Horm Res 2003; 59: 180-183.
27. Cole TJ, Roede MJ: Centiles of body mass index for Dutch children aged 0-20 years in 1980 - a baseline to assess recent trends in obesity. Ann Hum Biol 1999; 26: 303-308.
28. Rikken B, Van Doorn J, Ringeling A, Van den Brande JL, Massa G, Wit JM: Plasma levels of insulin-like growth factorIGF)-I, IGF-II and IGF- binding protein-3 in the evaluation of childhood growth hormone deficiency. Horm Res 1998; 50: 166-176.
29. Ross HA, Lentjes E, Menheere PP: The consensus statement on the standardization and evaluation of growth hormone and insulinlike growth factor assays lacks a recommendation to attempt efficacious harmonization. Clin Chem 2011; 57: 1463-1464.
30. Martin JL, Baxter RC: Insulin-like growth factor-binding protein from human plasma. Purification and characterization. J Biol Chem 1986; 261: 8754-8760.
31. Nannya Y, Sanada M, Nakazaki K, Hosoya N, Wang L, Hangaishi A, Kurokawa M, Chiba S, Bailey DK, Kennedy GC, Ogawa S: A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 2005; 65: 6071-6079.
32. Hwa V, Little B, Kofoed EM, Rosenfeld RG: Transcriptional regulation of insulin-like growth factor-I by interferon- requires STAT-5b. J Biol Chem 2004; 279: 2728-2736.
33. Maamra M, Finidori J, Von LS, Simon S, Justice S, Webster J, Dower S, Ross R: Studies with a growth hormone antagonist and dualfluorescent confocal microscopy demonstrate that the full-length human growth hormone receptor, but not the truncated isoform, is very rapidly internalized independent of Jak2-Stat5 signaling. J Biol Chem 1999; 274: 14791-14798.
34. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR: A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248-249.
35. Scaglia P, Domene HM, Martinez A, Keselman A, Pipman P, Bengolea SV, Karabatas L, Ropelato G, Lescano E, Ballerini G, Heinrich J, Jasper H: Heterozygous IGFALS gene mutations are present in both idiopathic short statureISS) and normal children: impact on height, and acid-labile subunitALS) levels; 2009, p 246.
36. Guida MC, Nistchke R, Domene HM, Karabatas L, Scaglia P, Martinez A, Keselman A, Bergada I, Cassinelli H, Bengolea SV, Heinrich JJ, Pipman V, Ropelato MG, Ballerini MG, Rey RA, Jasper HG: Intracellular trafficking effects of insulin-like growth factor acid labile subunit geneIGFALSD) mutations identified in idiopathic short statureISS) children; 2010, p 4.
37. Savage MO, Camacho-Hubner C, David A, Metherell LA, Hwa V, Rosenfeld RG, Clark AJ: Idiopathic short stature: will genetics influence the choice between GH and IGF-I therapy? Eur J Endocrinol 2007; 157(suppl 1):S33-S37.
38. Pantel J, Legendre M, Nivot S, Morisset S, Vie-Luton MP, Le Bouc Y, Epelbaum J, Amselem S: Recessive isolated growth hormone deficiency and mutations in the ghrelin receptor. J Clin. Endocrinol. Metab. 2009; 94: 4334-4341.
39. Inoue H, Kangawa N, Kinouchi A, Sakamoto Y, Kimura C, Horikawa R, Shigematsu Y, Itakura M, Ogata T, Fujieda K: Identification and functional analysis of novel human growth hormone secretagogue receptorGHSR) gene mutations in Japanese subjects with short stature. J Clin. Endocrinol. Metab. 2011; 96:E373-E378.
40. Pugliese-Pires PN, Fortin JP, Arthur T, Latronico AC, Mendonca BB, Villares SM, Arnhold IJ, Kopin AS, Jorge AA: Novel inactivating mutations in the GH secretagogue receptor gene in patients with constitutional delay of growth and puberty. Eur J Endocrinol 2011; 165: 233-241.
41. Rhoads RP, Greenwood PL, Bell AW, Boisclair YR: Organization and regulation of the gene encoding the sheep acid-labile subunit of the 150-kilodalton insulin-like growth factor-binding protein complex. Endocrinology 2000; 141: 1425-1433.
42. Suwanichkul A, Boisclair YR, Olney RC, Durham SK, Powell DR: Conservation of a growth hormone-responsive promoter element in the human and mouse acid-labile subunit genes. Endocrinology 2000; 141: 833-838.
43. Dauber A, Yu Y, Turchin MC, Chiang CW, Meng YA, Demerath EW, Patel SR, Rich SS, Rotter JI, Schreiner PJ, Wilson JG, Shen Y, Wu BL, Hirschhorn JN: Genome-wide association of copy-number variation reveals an association between short stature and the presence of low-frequency genomic deletions. Am J Hum Genet 2011; 89: 751-759.